LONDON, April 24, 2015 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Investor-Edge.com has issued free post--earnings research on Bed Bath & Beyond Inc. (NASDAQ: BBBY). On April 08, 2015, the company reported its financial results for Q4 FY14 and full-year FY14 (period ended February 28, 2015). Click on http://get.Investor-Edge.com/pdf/?c=Bed%20Bath%20and%20Beyond&d=24-Apr-2015&s=BBBY to read our free earnings review on Bed Bath and Beyond Inc. (Bed Bath and Beyond). During Q4 FY14 and FY14, the company's net sales increased 4.2% Y-o-Y and 3.3% Y-o-Y, respectively. Further, Bed Bath and Beyond's comparable sales improved 3.7% in Q4 FY14 and approximately 2.4% in full-year FY15. Our free coverage report can be accessed at:
During Q4 FY14, Bed Bath and Beyond reported net sales of $3.34 billion compared $3.20 billion in Q4 FY13. The company's Q4 FY14 net sales slightly missed Bloomberg analysts' forecasts of $3.37 billion. Moreover, the comparable sales growth in Q4 FY14 was approximately 3.7% compared with approximately 1.7% in Q4 FY13. The company's comparable sales for Q4 FY14 include an approximate 0.2% unfavorable impact from the change in the Canadian currency exchange rate.
For Q4 FY14, Bed Bath and Beyond's operating profit increased to $532.17 million from $527.07 million in Q4 FY13. The company's Q4 FY14 net earnings came in at $321.06 million, or $1.80 per diluted share, compared to $333.30 million, or $1.60 per diluted share, in Q4 FY13. Analysts from Bloomberg were expecting the company to report net earnings of $320.40 million, or $1.80 per diluted share, in Q4 FY14. Free research on BBBY can be downloaded in PDF format at:
Bed Bath and Beyond's net sales for FY14 was $11.88 billion compared to $11.50 billion in FY13. The company's net sales for FY14 fell short of Bloomberg analysts' forecasts of $11.91 billion. During FY14, the company's operating profit came in at $1.55 billion compared to $1.61 billion in FY13. The company's net earnings stood at $957.47 million, or $5.07 per diluted share, in FY14 compared to $1.02 billion, or $4.79 per diluted share, in FY13. Analysts from Bloomberg were expecting the retailer to report net earnings of $955.33 million, or $5.05 per diluted share, in FY14.
Bed Bath and Beyond excluded Cost Plus World Market from comparable sales calculations through the end of H1 FY13 and included it from beginning of Q3 FY13. The company also excluded Linen Holdings from comparable sales calculations and it will continue to be excluded on an ongoing basis as it represents non-retail activity. Sign up and read the free analyst's notes on BBBY at:
During Q4 FY14, Bed Bath and Beyond repurchased approximately 11.8 million shares of its common stock for approximately $947 million. The company repurchased approximately 10.3 million shares for approximately $782 million from open market, while the remaining 1.5 million shares worth $165 million, represented the net settlement at the completion of the company's $1.1 billion accelerated share repurchase program in December 2014. As of February 28, 2015, the remaining balance of the current $2.0 billion share repurchase program was approximately $884 million.
In FY14, Bed Bath and Beyond net cash provided by operating activities was $1.19 billion, compared to $1.39 billion in FY13. As of February 28, 2015, the company had cash and cash equivalents of $875.57 million compared to $366.52 million recorded as of March 01, 2014.
For its Q1 FY15 and full-year FY15 guidance, Bed Bath and Beyond expects comparable sales growth of 2.0% to 3.0%, respectively. Further, the company anticipates net earnings per diluted share to be between $0.90 and $0.95 for Q1 FY15 and a relatively flat to a mid-single digit percentage growth in net earnings per diluted share in FY15. Visit Investor-Edge and access the latest research on BBBY at:
On the day following the earnings release, April 09, 2015, Bed Bath and Beyond's stock plummeted 5.43% to end the session at $73.46. Since then, the stock has witnessed a mixed trend. On the last close, Thursday, April 23, 2015, the stock finished at $72.80, up 0.58%, after vacillating between $72.00 and $73.06. A total of 2.39 million shares were traded which was above their three months average volume of 2.04 million shares. Over the previous three trading sessions, the stock has advanced 0.68%. However, in the last one month and in the past three months, the company's shares have fallen by 3.33% and 4.99%, respectively. Shares in Bed Bath and Beyond closed above their 200-day moving average of $70.00. Furthermore, the stock traded at a PE ratio of 14.30 and has a Relative Strength Index (RSI) of 39.62.
Sneak Peek to Corporate Insider Trading
In the last one month, there were 3 insider transactions made by one individual. On April 13, 2015, Leonard Feinstein, Co-Chairman at Bed Bath and Beyond bought total of 165,970 shares of the company at an average price of $30.56 per share, and for a total value of $5.07 million. On the same day, he disposed an equal number of shares at an average price of $73.12 per share, and for a total value of $12.14 million. Complimentary in-depth research on BBBY is available at:
At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at compliance [at] www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.investor-edge.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-Edge, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Investor-Edge in this article or report according to the procedures outlined by Investor-Edge. Investor-Edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-Edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-Edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-Edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-Edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-Edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.